Intralipid Emulsion
Product Images NDC 0338-0519

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Intralipid (NDC 0338-0519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 Pbp (Bag 20pbp)

Label of Intralipid 20% (20 g/100 mL) intravenous fat emulsion in a 1000 mL pharmacy bulk package. The label includes a caution that it is not for direct infusion and indicates use is for intravenous administration. The product is labeled by Baxter Healthcare Corp with NDC 0338-0519.*

FDA Label Image

Image 2 (Inforuse20p Image2)

An instructional illustration showing hands removing the overwrap from a bag by tearing at the notch and pulling down along the container. It highlights two components at the bag's bottom labeled A (Oxalert sachet) and B (oxygen absorber), indicating the oxygen absorber should be discarded. The instructions advise placing the bag on a clean, flat surface or hanging it on a support hook.*

FDA Label Image

Image 3 (Inforuse20p Image3)

An instructional illustration showing a person breaking off the tamper-evident arrow flag from a blue infusion port. The diagram is accompanied by text instructions about using a compounding set with a specified diameter and following compounding set instructions.*

FDA Label Image

Image 4 (Inforuse20p Image4)

An illustration showing hands holding the base of an infusion port and inserting a spike straight through the center of the septum by rotating the wrist slightly as needed. The image includes instructions to ensure the spike insertion is straight, checks for particulates in the bag contents, and discards any bag with discoloration or particulates.*

FDA Label Image

Image 5 (Inforuse20p Image5)

An instructional diagram depicting a bag hanging from a hanger cut. The illustration highlights two ports or connectors at the bottom of the bag, with one connected to a transfer line. The accompanying instruction text advises hanging the bag and starting transfer to a compounding bag.*

FDA Label Image

Figure 1 (Instruct Fig1)

An instructional diagram displaying a rectangular bag with two ports labeled A and B, accompanied by an integrity indicator (Oxalert™). The diagram includes a note explaining that the integrity indicator A should be inspected prior to removing the overwrap. If the indicator is black, the overwrap is damaged and the product must be discarded.*

FDA Label Image

Fatad (Intralipid 20 Pbp Excel Container Figure 1 Fatacid Intralp)

Chemical structure diagram showing a triglyceride molecule with three fatty acid residues represented as R1, R2, and R3, characteristic of the emulsion components in Intralipid 20 g/100 mL by Baxter Healthcare Corp.*

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 10 Intra Figure8)

Chemical structure diagram of the active ingredient visually represented with multiple R groups, including R1, R2, and R3, and functional groups such as carboxyl and carbonyl moieties. The image does not name the ingredient explicitly but depicts a molecular structure typical for lipid-related compounds.*

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 11 Intra Figure9)

Chemical structure diagram showing two triglyceride molecules with variable side chains, consistent with lipid molecules found in Intralipid 20 g/100mL by Baxter Healthcare Corp.*

FDA Label Image

Figure (Intralipid 20 Pbp Excel Container Figure 12 Intra Figure)

Chemical structure diagrams of two components, likely related to Intralipid, depicting molecular arrangements with phosphate, carbonyl, and amine groups. The left and right structures show different organic side chains and functional groups characteristic of lipid molecules.*

FDA Label Image

Stuct (Intralipid 20 Pbp Excel Container Figure 13 Intra Figure12)

Chemical structure diagram of the active ingredient shown for Intralipid 20 g/100mL, a product labeled by Baxter Healthcare Corp.*

FDA Label Image

R1 (Intralipid 20 Pbp Excel Container Figure 2 R1c Intralip)

Chemical structure diagram showing a molecular formula with a carboxyl group (CO) and a variable side chain (R1 and R2), representing the chemical structure of an active ingredient related to the Intralipid product by Baxter Healthcare CORP.*

FDA Label Image

R2 (Intralipid 20 Pbp Excel Container Figure 3 R2c Intralip)

Chemical structure of Intralipid's active component, depicting a generic fatty acid ester with a carboxyl group (C=O) and variable R groups (R2). The diagram highlights the molecular framework relevant to lipid emulsions in the product.*

FDA Label Image

R3 (Intralipid 20 Pbp Excel Container Figure 4 R3c Intralp)

Chemical structure of the triglyceride component in Intralipid, showing three fatty acid chains (R3C) esterified to a glycerol backbone. The image illustrates the molecular arrangement typical of lipid emulsions.*

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 5 Intra Figure3)

Chemical structure of the active ingredient in Intralipid 20 g/100mL, as supplied by Baxter Healthcare CORP. The structure depicts a fatty acid chain with multiple double bonds and hydroxyl groups, characteristic of lipid molecules.*

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 6 Intra Figure4)

Chemical structure diagram showing the molecular formula of an active ingredient related to the product Intralipid 20 g/100 mL by Baxter Healthcare CORP.*

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 7 Intra Figure5)

Chemical structure diagram of Intralipid, showing the detailed molecular arrangement with carbon, hydrogen, and oxygen atoms representing the lipid molecule.*

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 8 Intra Figure6)

Chemical structure diagram of the active ingredient in Intralipid 20 g/100mL by Baxter Healthcare CORP. The image shows a detailed molecular structure with carbon, hydrogen, and oxygen atoms arranged in a complex lipid chain.*

FDA Label Image

Structure (Intralipid 20 Pbp Excel Container Figure 9 Intra Figure7)

Chemical structure of the active ingredient in Intralipid 20 g/100 mL, showing a molecular formula with a series of carbon (C) and hydrogen (H) atoms arranged in a chain with one carboxyl group (C=O-OH).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.